We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.00 | 14.00 | 36.00 | 25.00 | 25.00 | 25.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.86 | 37.33M |
RNS No 5210p CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC ** B L O C K L I S T I N G S I X M O N T H L Y R E V I E W ** ********************************************************** 1. NAME OF COMPANY: CAMBRIDGE ANTIBODY TECHNOLOGY GROUP PLC 2. NAME OF SCHEME: CAMBRIDGE ANTIBODY TECHNOLOGY SHARE OPTION SCHEME 3. PERIOD OF RETURN: FROM: 27 MARCH 1998 TO: 30 SEPTEMBER 1998 4. NUMBER AND CLASS OF SHARES(S) (AMOUNT OF STOCK/DEBT SECURITY) NOT ISSUED UNDER SCHEME AT END OF THE LAST PERIOD: 2,124,893 10P ORDINARY SHARES 5. NUMBER OF SHARES ISSUED/ALLOTTED UNDER SCHEME DURING PERIOD: 2,578 6. BALANCE UNDER SCHEME NOT YET ISSUED/ALLOTTED AT END OF PERIOD: 2,123,215 7. NUMBER AND CLASS OF SHARE(S) (AMOUNT OF STOCK/DEBT SECURITIES) ORIGINALLY LISTED AND THE DATE OF ADMISSION: 22,136,251 10P ORDINARY SHARES 25 MARCH 1997 PLEASE CONFIRM TOTAL NUMBER OF SHARES IN ISSUE AT THE END OF THE PERIOD IN ORDER FOR US TO UPDATE OUR RECORDS. 23,492,584 10P ORDINARY SHARES CONTACT FOR QUERIES: NAME: MISS DIANE MELLETT TELEPHONE: 01763 263233 END BLRLZFFLVLKFFKB
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions